El AL may drop purchase of Boeing airliners

November 14, 2006 22:28


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


El Al, is considering dropping an option to buy up to 10 of Boeing's new 787 jetliner, but could still decide to buy the new generation long haul aircraft , a spokesman for the airline said Tuesday. Spokesman Ran Rahav said El Al announced its intention not to exercise its option to buy eight to 10 of the aircraft - due to enter service with airlines around the globe in May 2008 - but he said the airline has yet to make a final decision on placing an order. "We said yesterday that we want to cancel the order because of the state of the airline business worldwide," Rahav said. "But we're still thinking about it." Business journal The Marker, said that if El Al nevertheless decided to place a new order it would now have to wait until the year 2014 for delivery, having lost its place in the queue.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection